Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 2
1973 3
1975 5
1976 6
1977 9
1979 3
1980 2
1981 3
1982 2
1983 8
1984 8
1985 13
1986 11
1987 17
1988 11
1989 16
1990 20
1991 10
1992 8
1993 12
1994 9
1995 6
1996 8
1997 7
1998 4
1999 7
2000 4
2001 8
2002 3
2003 5
2004 6
2005 3
2006 6
2007 6
2008 5
2009 7
2010 7
2011 10
2012 8
2013 6
2014 3
2015 5
2016 9
2017 10
2018 11
2019 9
2020 9
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

346 results
Results by year
Filters applied: . Clear all
Page 1
Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma.
Yu AL, Gilman AL, Ozkaynak MF, London WB, Kreissman SG, Chen HX, Smith M, Anderson B, Villablanca JG, Matthay KK, Shimada H, Grupp SA, Seeger R, Reynolds CP, Buxton A, Reisfeld RA, Gillies SD, Cohn SL, Maris JM, Sondel PM; Children's Oncology Group. Yu AL, et al. Among authors: sondel pm. N Engl J Med. 2010 Sep 30;363(14):1324-34. doi: 10.1056/NEJMoa0911123. N Engl J Med. 2010. PMID: 20879881 Free PMC article. Clinical Trial.
Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group.
Mody R, Yu AL, Naranjo A, Zhang FF, London WB, Shulkin BL, Parisi MT, Servaes SE, Diccianni MB, Hank JA, Felder M, Birstler J, Sondel PM, Asgharzadeh S, Glade-Bender J, Katzenstein H, Maris JM, Park JR, Bagatell R. Mody R, et al. Among authors: sondel pm. J Clin Oncol. 2020 Jul 1;38(19):2160-2169. doi: 10.1200/JCO.20.00203. Epub 2020 Apr 28. J Clin Oncol. 2020. PMID: 32343642 Free PMC article. Clinical Trial.
Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19.
Ascierto PA, Fox BA, Urba WJ, Anderson AC, Atkins MB, Borden EC, Brahmer JR, Butterfield LH, Cesano A, Chen DC, de Gruijl TD, Dillman RO, Drake CG, Emens LA, Gajewski TF, Gulley JL, Stephen Hodi FJ, Hwu P, Kaufman D, Kaufman HL, Lotze MT, McNeel DG, Margolin KM, Marincola FM, Mastrangelo MJ, Maus MV, Parkinson DR, Romero PJ, Sondel PM, Spranger S, Sznol M, Weiner GJ, Wigginton JM, Weber JS. Ascierto PA, et al. Among authors: sondel pm. J Immunother Cancer. 2020 Apr;8(1):e000878. doi: 10.1136/jitc-2020-000878. J Immunother Cancer. 2020. PMID: 32300051 Free PMC article. No abstract available.
Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial.
Mody R, Naranjo A, Van Ryn C, Yu AL, London WB, Shulkin BL, Parisi MT, Servaes SE, Diccianni MB, Sondel PM, Bender JG, Maris JM, Park JR, Bagatell R. Mody R, et al. Among authors: sondel pm. Lancet Oncol. 2017 Jul;18(7):946-957. doi: 10.1016/S1470-2045(17)30355-8. Epub 2017 May 23. Lancet Oncol. 2017. PMID: 28549783 Free PMC article. Clinical Trial.
Immunotherapy for pediatric cancer.
Grupp SA, Verneris M, Sondel PM, Cooper LJ. Grupp SA, et al. Among authors: sondel pm. Biol Blood Marrow Transplant. 2008 Jan;14(1 Suppl 1):33-43. doi: 10.1016/j.bbmt.2007.10.014. Biol Blood Marrow Transplant. 2008. PMID: 18162219 Free PMC article. Review.
NK cell-based immunotherapies in Pediatric Oncology.
McDowell KA, Hank JA, DeSantes KB, Capitini CM, Otto M, Sondel PM. McDowell KA, et al. Among authors: sondel pm. J Pediatr Hematol Oncol. 2015 Mar;37(2):79-93. doi: 10.1097/MPH.0000000000000303. J Pediatr Hematol Oncol. 2015. PMID: 25590232 Free PMC article. Review.
T-cell-independent antitumor effects of CD40 ligation.
Rakhmilevich AL, Alderson KL, Sondel PM. Rakhmilevich AL, et al. Among authors: sondel pm. Int Rev Immunol. 2012 Aug;31(4):267-78. doi: 10.3109/08830185.2012.698337. Int Rev Immunol. 2012. PMID: 22804571 Free PMC article. Review.
346 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page